Former Biogen R&D Chief Resurfaces at $80M Startup Codiak Biosciences Pursuing Cancer, Alzheimer’s

Codiak Biosciences

Doug Williams left one of biotechnology’s biggest R&D jobs, at Biogen, in July. Now we know why. Williams is now the founding CEO of Codiak Biosciences, a Cambridge, Mass.-based startup. The little company is announcing today it has raised $80 million in committed venture capital spread over two installments. Two venture firms known for creating…

Read More